Guardant Health Price to Book Ratio 2017-2021 | GH

Historical price to book ratio values for Guardant Health (GH) over the last 10 years. The current price to book ratio for Guardant Health as of October 22, 2021 is 14.06.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Guardant Health Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 109.35 14.05
2021-06-30 124.19 $7.78 15.96
2021-03-31 152.65 $8.38 18.22
2020-12-31 128.88 $12.96 9.95
2020-09-30 111.78 $10.93 10.22
2020-06-30 81.13 $11.22 7.23
2020-03-31 69.60 $8.31 8.38
2019-12-31 78.14 $8.47 9.23
2019-09-30 63.83 $8.69 7.35
2019-06-30 86.33 $8.79 9.82
2019-03-31 76.70 $5.44 14.11
2018-12-31 37.59 $5.63 6.68
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.077B $0.287B
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76